Literature DB >> 1907674

Effect of taurine on total parenteral nutrition-associated cholestasis.

F Guertin1, C C Roy, G Lepage, A Perea, R Giguère, I Yousef, B Tuchweber.   

Abstract

A decrease in the formation/secretion of bile has been well documented in animals on total parenteral nutrition (TPN). Either an excess or an imbalance of amino acids (AA) has been most often implicated. In view of recent work showing that taurine promotes bile flow, bile acid secretion, and protects against hepatotoxic bile acids, the effect of adding taurine (15 mg/dL) to an AA solution was examined in guinea pigs on TPN for 3 days. The TPN-taurine group had a larger bile flow than the group without taurine and had bile acid secretory rates (BASR) similar to those of controls who were on saline by central catheter and had free access to food. Bile composition showed an increase in the secondary bile acid, 7-ketolithocholate and a concomitant decrease in chenodeoxycholate (CDC) in both experimental groups. Taurine led to a reversal of the usual predominance of glycine over taurine conjugated bile acids as well as to increases in HCO3 in cholesterol secretion. In response to a challenge with a large load of CDC, the TPN-taurine animals increased their BASR beyond those observed in the two other groups. These observations suggest that the addition of taurine to TPN solutions could play a role in the prevention of altered biliary function associated with AA solutions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907674     DOI: 10.1177/0148607191015003247

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  7 in total

1.  Taurine and cholestasis associated to TPN. Experimental study in rabbit model.

Authors:  J M Moran; J Salas; F Botello; E Macià; V Climent
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

Review 2.  Small intestinal transplantation for irreversible intestinal failure in children.

Authors:  S A Kocoshis; J Reyes; S Todo; T E Starzl
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

Review 3.  Innovative parenteral and enteral nutrition therapy for intestinal failure.

Authors:  Hau D Le; Erica M Fallon; Vincent E de Meijer; Alpin D Malkan; Mark Puder; Kathleen M Gura
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

4.  Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters.

Authors:  Narges Abdoli; Issa Sadeghian; Negar Azarpira; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Clin Exp Hepatol       Date:  2021-03-25

Review 5.  Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease.

Authors:  Swagatika Sahoo; Maike K Aurich; Jon J Jonsson; Ines Thiele
Journal:  Front Physiol       Date:  2014-03-11       Impact factor: 4.566

6.  Activation of glycine and extrasynaptic GABA(A) receptors by taurine on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis.

Authors:  Thi Thanh Hoang Nguyen; Janardhan Prasad Bhattarai; Soo Joung Park; Seong Kyu Han
Journal:  Neural Plast       Date:  2013-11-28       Impact factor: 3.599

7.  Effects of different carbohydrate sources on taurine status in healthy Beagle dogs.

Authors:  Julia Guazzelli Pezzali; Heather L Acuff; Will Henry; Celeste Alexander; Kelly S Swanson; Charles G Aldrich
Journal:  J Anim Sci       Date:  2020-02-01       Impact factor: 3.159

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.